Biodesix to Participate in Three Upcoming Investor Conferences

LOUISVILLE, Colo., Sept. 03, 2026 /CourierPR/ -- Biodesix, a leading diagnostics solutions company, will participate in three upcoming investor conferences to showcase its latest advancements and engage with key stakeholders.

At Lake Street Capital Markets’ 10th Annual Best Ideas Growth (BIG10) Conference, held on Thursday, September 10, in New York, NY, members of Biodesix’s leadership team will conduct one-on-one meetings only.

The company will also present at the H.C. Wainwright 28th Annual Global Investment Conference on Tuesday, September 15, also in New York, with similar one-on-one meeting formats.

A highlight of these events will be Biodesix’s presentation at the 5th Annual Roth Healthcare Opportunities Conference, where Gary Pestano, Ph.D., Chief Scientific Officer, will participate in a panel discussion and one-on-one meetings. The panel, titled "The Rise of MRD Monitoring in Solid Tumors, and Where it Goes Next," is scheduled for Tuesday, September 29, at 2:00 PM Eastern Time, also in New York.

Biodesix’s diagnostic tests, such as Nodify Lung® Nodule Risk Assessment and IQLung® Cancer Treatment Guidance, are designed to support clinical decisions, facilitating personalized care and improved outcomes for patients with lung disease. The company’s development services provide scientific, technological, and operational capabilities to biopharmaceutical, life sciences, and research institutions, supporting the development of diagnostic tests, tools, and therapeutics.